Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon T McInnes

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The American Journal of Cardiology|December 16, 2011
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertensionStevo Julius, Paolo Palatini, Sverre E Kjeldsen, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2014
Response to Effect of serum chloride on mortality in hypertensive patientsLinsay McCallum, Panniyammakal Jeemon, Claire E Hastie, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2013
Serum chloride is an independent predictor of mortality in hypertensive patientsLinsay McCallum, Panniyammakal Jeemon, Claire E Hastie, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Journal of Hypertension|October 21, 2006
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trialAlberto Zanchetti, Stevo Julius, Sverre Kjeldsen, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapyStevo Julius, Michael A Weber, Sverre E Kjeldsen, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The American Journal of Cardiology|December 16, 2011
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertensionStevo Julius, Paolo Palatini, Sverre E Kjeldsen, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2014
Response to Effect of serum chloride on mortality in hypertensive patientsLinsay McCallum, Panniyammakal Jeemon, Claire E Hastie, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2013
Serum chloride is an independent predictor of mortality in hypertensive patientsLinsay McCallum, Panniyammakal Jeemon, Claire E Hastie, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Journal of Hypertension|October 21, 2006
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trialAlberto Zanchetti, Stevo Julius, Sverre Kjeldsen, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapyStevo Julius, Michael A Weber, Sverre E Kjeldsen, et al.
Pageof 6